The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Shares of Sun Pharma Advanced Research Company (SPARC ... experts before taking any investment decisions. Advisory Alert: It has come to our attention that certain individuals are representing ...
Sun Pharma Advanced Research Company Ltd. announced the results of the interim analysis from the Proseek study, a global Phase 2 study in patients with early Parkinson’s Disease. The study ...
On April 10, Sun Pharma Advanced Research Company (SPARC) shares dropped 5% to reach the lower circuit following the Mumbai-based pharmaceutical company's announcement that it was giving up on its ...
Mumbai-based pharmaceutical company, Sun Pharma Advanced Research Company Ltd. (SPARC), said it was abandoning its Phase 2 study on Vodobatinib for Parkinson's. The study was designed to evaluate ...
It has picked Sun Pharma, JB Chemicals, Eris Lifesciences and Torrent Pharma as its top picks Dalal Street is all set to kick start the earnings season for the quarter ended March 2024.
Sensex at 75,000 : Reliance Industries, Tata Motors, Mahindra & Mahindra , Sun Pharmaceutical Industries, Maruti Suzuki, State Bank of India, Bharti Airtel, NTPC , Power Grid Corporation of India ...
On 4 April, Amylyx Pharmaceuticals announced it was withdrawing its ALS drug Relyvrio from the market after disappointing Phase III data, with the trial failing to meet a single endpoint. The ...
Sun Pharma Advanced Research’s stock rallied sharply towards the end of 2023. But since the beginning of this year, it was largely trading in a broad sideways trend. Last week, it gained nearly ...
After two prior attempts to win FDA approval for its apomorphine infusion device for the continuous treatment of motor fluctuations (or “off” episodes) in Parkinson’s patients, the agency ...
On April 8, 2024, Amring begins to operate and transact, through its 3PL (ICS) as Nordic Pharma. "Since the announcement, we have been diligently working on updating our appropriate state ...